— Know what they know.
Not Investment Advice
Also trades as: 0HRS.L (LSE) · $vol 1M · CVS.DE (XETRA) · $vol 0M

CVS NYSE

CVS Health Corp.
1W: -3.2% 1M: +3.7% 3M: -14.0% YTD: +14.6% 1Y: +11.2% 3Y: +43.3% 5Y: +23.8%
$91.13
-1.40 (-1.51%)
 
Weekly Expected Move ±3.4%
$87 $90 $93 $97 $100
NYSE · Healthcare · Medical - Healthcare Plans · Tech Score Buy · Power 70 · $116.6B mcap · 1.28B float · 0.628% daily turnover · Short 50% of daily vol
Credit Risk of going bust: lower than 59% of companies Debt: 39.6% of company value Bonds: $1.86B held by 970 funds, 98 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $3.01 (down 97%), CVS Health Corp. would be worth roughly what it owes.
Total debt $76.31B against a stock market value of $116.55B.
Distance to default 6.07 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $31.68B (short-term plus half of long-term), stock volatility 32.1%; Altman Z'' 1.25. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Balance Sheet Trends

Total Assets
$261.1B +3.1% ▲
5Y CAGR: +2.5%
Total Liabilities
$185.7B +4.6% ▲
5Y CAGR: +2.9%
Shareholders Equity
$75.2B -0.5% ▼
5Y CAGR: +1.6%
Cash & Investments
$10.7B -3.1% ▼
5Y CAGR: -0.4%
Total Debt
$93.6B +12.9% ▲
5Y CAGR: +1.9%
Net Debt
$85.1B +14.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$9.4B$12.9B$8.2B$8.6B$8.5B
Short-Term Investments$3.1B$2.8B$3.3B$2.4B$2.1B
Cash & ST Investments$12.5B$15.7B$11.5B$11.0B$10.7B
Net Receivables$24.4B$27.3B$35.2B$36.5B$39.8B
Inventory$17.8B$19.1B$18.0B$18.1B$19.2B
Other Current Assets$5.3B$3.5B$3.2B$3.1B$5.0B
Total Current Assets$60.0B$65.6B$67.9B$68.6B$74.7B
Property, Plant & Equip.$32.0B$30.7B$30.4B$28.9B$28.1B
Goodwill & Intangibles$108.1B$103.0B$120.5B$118.6B$111.0B
Long-Term Investments$23.0B$21.1B$23.0B$28.9B$32.9B
Other Non-Current Assets$9.8B$7.8B$7.9B$8.1B$6.9B
Total Non-Current Assets$173.0B$162.6B$181.9B$184.6B$186.3B
Total Assets$233.0B$228.3B$249.7B$253.2B$261.1B
— Liabilities —
Accounts Payable$12.5B$14.8B$14.9B$15.9B$59.4B
Short-Term Debt$4.2B$1.8B$3.0B$5.7B$5.8B
Deferred Revenue$0$0$0$0$62M
Other Current Liabilities$5.6B$2.8B$2.5B$1.2B$23.4B
Total Current Liabilities$67.8B$69.4B$79.2B$84.6B$88.7B
Long-Term Debt$52.0B$50.5B$58.6B$60.5B$72.9B
Other Non-Current Liab.$13.4B$15.8B$14.9B$13.6B-$2.2B
Total Non-Current Liabilities$89.8B$87.1B$93.9B$92.9B$97.0B
Total Liabilities$157.6B$156.5B$173.1B$177.5B$185.7B
— Equity —
Common Stock$47.4B$48.2B$49.0B$18M$18M
Retained Earnings$54.9B$56.4B$61.6B$62.8B$61.2B
Accumulated OCI$965M-$1.3B-$297M-$120M$406M
Total Stockholders Equity$75.1B$71.5B$76.5B$75.6B$75.2B
Total Liabilities & Equity$233.0B$228.3B$249.7B$253.2B$261.1B
— Key Metrics —
Total Debt$76.0B$70.7B$79.4B$82.9B$93.6B
Net Debt$66.6B$57.8B$71.2B$74.3B$85.1B
Total Investments$26.1B$23.9B$26.3B$31.3B$35.0B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms